Email this article 
Hide
Show all
VITAMIN D AND SEROTONIN’S ROLE IN NEUROPSYCHIATRIC DISORDERS
Abstract
Vitamin D is known to play an active role in the development of nerve cells, as well as regulating the expression of one of the important genes in serotonin metabolism, namely THP2. Vitamin D and serotonin play an important role in the development of various neuropsychiatric diseases, Autism spectrum disorder (ASD), schizophrenia, bipolar disorder, and depression. Method: An article review was carried out by tracing various scientific literature relating to theories regarding the relationship of vitamin D and Serotonin, as well as neuropsychiatric disorders related to metabolic disorders and the production of vitamin D and serotonin. Results: The biological activity of vitamin D is mediated by the vitamin D receptor (VDR). The bonding complex between VDR and VDRE in the promoter of a gene will initiate the transcription process, one of which is TPH2, which plays an active role in the synthesis of brain serotonin. Serotonin has an important role as a neurotransmitter, hormone and morphogen for the brain. This neurotransmitter have important functions in the brain in controlling appetite, energy expenditure, sleep, body temperature, mood, and social cognition. Conclusion: Vitamin D plays an active role in the transcription of TPH2, which plays an active role in the synthesis of brain serotonin. Vitamin D facilitate tryptophan metabolism by increasing TPH2 to synthesize serotonin. Disruption of vitamin D levels will change serotonin levels and function in the brain, resulting in impaired behavior and executive brain function.
Keyword: Vitamin D, Serotonin, Autism, Autism Spectrum Disorder
Full Text:
PDFReferences
Altun, H. et al. (2018) ‘The Levels of Vitamin D , Vitamin D Receptor , Homocysteine and Complex B Vitamin in Children with Autism Spectrum Disorders’, 16(4), pp. 383–390.
Anjum, I. et al. (2018) ‘The Role of Vitamin D in Brain Health : A Mini Literature Review’, Cureus, 10(7). doi: 10.7759/cureus.2960.
Bikle, D. D. (2014) ‘Review Vitamin D Metabolism , Mechanism of Action , and Clinical Applications’, Chemistry & Biology. Elsevier Ltd, 21(3), pp. 319–329. doi: 10.1016/j.chembiol.2013.12.016.
Christakos, S. et al. (2010) ‘Vitamin D: Metabolism’, Endocrinol Metab Clin North Am, 39(2), pp. 243–253. doi: 10.1016/j.ecl.2010.02.002.Vitamin.
Christakos, S. et al. (2016) ‘VITAMIN D : METABOLISM , MOLECULAR MECHANISM OF ACTION , AND PLEIOTROPIC EFFECTS’, Physiol Rev, 96, pp. 365–408. doi: 10.1152/physrev.00014.2015.
Eyles, D. and Mcgrath, J. (2018) ‘Chapter 33 - Vitamin D Brain Development and Function’, in Vitamin D, Volume 1: Biochemistry, Physiology and Diagnostics, Fourth Edition. Fourth Edi. Elsevier Inc., pp. 563–581. doi: 10.1016/B978-0-12-809965-0.00033-1.
Jia, F. et al. (2019) ‘Core Symptoms of Autism Improved After Vitamin D Supplementation’, Pediatrics, 135(1). doi: 10.1542/peds.2014-2121.
Kesby, J. P. et al. (2016) ‘Review Vitamin D Metabolism , Mechanism of Action , and Clinical Applications’, Chemistry & Biology. Elsevier Ltd, 96(3), pp. 365–408. doi: 10.1016/j.chembiol.2013.12.016.
Koc, E. and Meier, U. (2017) ‘Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism’, frontiers in psychiatry, 8(March), pp. 1–11. doi: 10.3389/fpsyt.2017.00047.
Lee, B. K. et al. (2019) ‘Developmental vitamin D and autism spectrum disorders : fi ndings from the Stockholm Youth Cohort’, Molecular Psychiatry. Springer US. doi: 10.1038/s41380-019-0578-y.
Lee, D. M. et al. (2009) ‘Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men’, J Neurol Neurosurg Psychiatry, 25, pp. 722–729. doi: 10.1136/jnnp.2008.165720.
Mazahery, H. et al. (2016) ‘Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder : a study protocol for a factorial randomised , double-blind ’, Trials, 17(295), pp. 1–13.
Nordquist, N. and Oreland, L. (2010) ‘Serotonin , genetic variability , behaviour , and psychiatric disorders - a review’, Upsala Journal of Medical Sciences ISSN:, 115(1), pp. 2–10. doi: 10.3109/03009730903573246.
Patrick, R. P. and Ames, B. N. (2015) ‘Vitamin D and the omega-3 fatty acids control serotonin synthesis and action , part 2 : relevance for ADHD , bipolar , schizophrenia , and impulsive behavior’, the FASEB Journal, pp. 1–16. doi: 10.1096/fj.14-268342.
Saad, K. et al. (2015) ‘Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children’, Nutritional Neuroscience, 8305(February 2016). doi: 10.1179/1476830515Y.0000000019.
Sabir, M. S. et al. (2018) ‘Optimal vitamin D spurs serotonin : 1 , 25-dihydroxyvitamin D represses serotonin reuptake transport ( SERT ) and degradation ( MAO-A ) gene expression in cultured rat serotonergic neuronal cell lines’, Genes & Nutrition. Genes & Nutrition, 13(19), pp. 1–11.
Shi, H., Wang, B. and Xu, X. (2017) ‘Antidepressant Effect of Vitamin D : A Literature Review’, Neuropsychiatry, 7(4), pp. 337–341.
Zhang, Z. et al. (2018) ‘Polymorphisms in Vitamin D Receptor Genes in Association with Childhood Autism Spectrum Disorder’, Disease Markers. Hindawi, 2018, pp. 1–7. doi: 10.1155/2018/7862892.
DOI: https://doi.org/10.24260/raheema.v7i1.1797
Article Metrics
Abstract view : 951 timesPDF - 585 times
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.